Related Experiment Videos
Bacterial meningitis
1Division of Internal Medicine, University of Florida College of Medicine, Gainesville, Florida, USA
Abstract:
With nearly 8,000 cases in the United States per year, and 2,000 deaths annually, bacterial meningitis continues to be a significant source of morbidity and mortality. The principal pathogens are Neisseria meningitidis, Streptococcus pneumoniae, group B streptococci, and Hemophilus influenzae. In immunocompromised patients, Listeria monocytogenes is also an important pathogen. Rapid identification and evaluation of the patient with bacterial meningitis and prompt initiation of antibiotics are the cornerstones of therapy. Except in the rare patient with papilledema, focal neurologic symptoms, or a seizure, a lumbar puncture should be performed without delay, and antibiotic therapy should be administered promptly. Patients without a readily identifiable source of infection should be treated empirically with intravenous ceftriaxone. Ampicillin should also be administered in populations at increased risk for L. monocytogenes. The risk of meningitis in some populations can be reduced by administration of vaccines against selected pathogens such as N. meningitidis, S. pneumoniae, and H. influenzae.
Insights
Bacterial meningitis causes significant illness and death in the US. Prompt diagnosis, antibiotic treatment, and vaccinations are key to reducing its impact.
Area of Science:
- Infectious Diseases
- Neurology
- Public Health
Background:
- Bacterial meningitis remains a major cause of illness and death in the US, with nearly 8,000 cases and 2,000 deaths annually.
- Key pathogens include Neisseria meningitidis, Streptococcus pneumoniae, group B streptococci, and Hemophilus influenzae, with Listeria monocytogenes being significant in immunocompromised individuals.
Purpose of the Study:
- To outline the critical steps in the diagnosis and management of bacterial meningitis.
- To emphasize the importance of prompt treatment and preventive strategies.
Main Methods:
- The abstract discusses the diagnostic approach, emphasizing early lumbar puncture and prompt antibiotic administration.
- It details empirical treatment strategies, including the use of ceftriaxone and ampicillin for specific risk groups.
Main Results:
- Rapid identification and treatment are crucial for improving outcomes in bacterial meningitis.
- Empirical antibiotic therapy with ceftriaxone, and ampicillin when indicated, forms the basis of treatment.
- Vaccination against common bacterial meningitis pathogens can reduce disease incidence.
Conclusions:
- Prompt lumbar puncture and initiation of appropriate antibiotic therapy are essential for managing bacterial meningitis.
- Vaccination strategies play a vital role in the prevention of meningitis in at-risk populations.